COAGULATION AND FIBRINOLYTIC STUDIES IN WOMEN RECEIVING AN ANOVULATORY DRUG (MEDROXYPROGESTERONE ACETATE WITH ESTRADIOL).
D001777:Blood Coagulation; D003270:Contraceptive Agents; D003276:Contraceptives, Oral; D004958:Estradiol / Q000627:therapeutic use*; D005260:Female; D005342:Fibrinolysis; D006801:Humans; D008525:Medroxyprogesterone; D017258:Medroxyprogesterone Acetate; D010600:Pharmacology; D014116:Toxicology
D003270:Contraceptive Agents; D003276:Contraceptives, Oral; D004958:Estradiol; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone
BLOOD COAGULATION; CONTRACEPTIVES, ORAL; ESTRADIOL, THERAPEUTIC; FIBRINOLYSIS; MEDROXYPROGESTERONE; PHARMACOLOGY; TOXICOLOGIC REPORT